• Je něco špatně v tomto záznamu ?

Phospholipid profiling enables to discriminate tumor- and non-tumor-derived human colon epithelial cells: Phospholipidome similarities and differences in colon cancer cell lines and in patient-derived cell samples

J. Hofmanová, J. Slavík, P. Ovesná, Z. Tylichová, L. Dušek, N. Straková, AH. Vaculová, M. Ciganek, Z. Kala, M. Jíra, I. Penka, J. Kyclová, Z. Kolář, A. Kozubík, M. Machala, J. Vondráček,

. 2020 ; 15 (1) : e0228010. [pub] 20200130

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023215

Grantová podpora
NV15-30585A MZ0 CEP - Centrální evidence projektů

Identification of changes of phospholipid (PL) composition occurring during colorectal cancer (CRC) development may help us to better understand their roles in CRC cells. Here, we used LC-MS/MS-based PL profiling of cell lines derived from normal colon mucosa, or isolated at distinct stages of CRC development, in order to study alterations of PL species potentially linked with cell transformation. We found that a detailed evaluation of phosphatidylinositol (PI) and phosphatidylserine (PS) classes allowed us to cluster the studied epithelial cell lines according to their origin: i) cells originally derived from normal colon tissue (NCM460, FHC); ii) cell lines derived from colon adenoma or less advanced differentiating adenocarcinoma cells (AA/C1, HT-29); or, iii) cells obtained by in vitro transformation of adenoma cells and advanced colon adenocarcinoma cells (HCT-116, AA/C1/SB10, SW480, SW620). Although we tentatively identified several PS and PI species contributing to cell line clustering, full PI and PS profiles appeared to be a key to the successful cell line discrimination. In parallel, we compared PL composition of primary epithelial (EpCAM-positive) cells, isolated from tumor and adjacent non-tumor tissues of colon cancer patients, with PL profiles of cell lines derived from normal colon mucosa (NCM460) and from colon adenocarcinoma (HCT-116, SW480) cells, respectively. In general, higher total levels of all PL classes were observed in tumor cells. The overall PL profiles of the cell lines, when compared with the respective patient-derived cells, exhibited similarities. Nevertheless, there were also some notable differences in levels of individual PL species. This indicated that epithelial cell lines, derived either from normal colon tissue or from CRC cells, could be employed as models for functional lipidomic analyses of colon cells, albeit with some caution. The biological significance of the observed PL deregulation, or their potential links with specific CRC stages, deserve further investigation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023215
003      
CZ-PrNML
005      
20201214125515.0
007      
ta
008      
201125s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0228010 $2 doi
035    __
$a (PubMed)31999740
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Hofmanová, Jiřina $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic.
245    10
$a Phospholipid profiling enables to discriminate tumor- and non-tumor-derived human colon epithelial cells: Phospholipidome similarities and differences in colon cancer cell lines and in patient-derived cell samples / $c J. Hofmanová, J. Slavík, P. Ovesná, Z. Tylichová, L. Dušek, N. Straková, AH. Vaculová, M. Ciganek, Z. Kala, M. Jíra, I. Penka, J. Kyclová, Z. Kolář, A. Kozubík, M. Machala, J. Vondráček,
520    9_
$a Identification of changes of phospholipid (PL) composition occurring during colorectal cancer (CRC) development may help us to better understand their roles in CRC cells. Here, we used LC-MS/MS-based PL profiling of cell lines derived from normal colon mucosa, or isolated at distinct stages of CRC development, in order to study alterations of PL species potentially linked with cell transformation. We found that a detailed evaluation of phosphatidylinositol (PI) and phosphatidylserine (PS) classes allowed us to cluster the studied epithelial cell lines according to their origin: i) cells originally derived from normal colon tissue (NCM460, FHC); ii) cell lines derived from colon adenoma or less advanced differentiating adenocarcinoma cells (AA/C1, HT-29); or, iii) cells obtained by in vitro transformation of adenoma cells and advanced colon adenocarcinoma cells (HCT-116, AA/C1/SB10, SW480, SW620). Although we tentatively identified several PS and PI species contributing to cell line clustering, full PI and PS profiles appeared to be a key to the successful cell line discrimination. In parallel, we compared PL composition of primary epithelial (EpCAM-positive) cells, isolated from tumor and adjacent non-tumor tissues of colon cancer patients, with PL profiles of cell lines derived from normal colon mucosa (NCM460) and from colon adenocarcinoma (HCT-116, SW480) cells, respectively. In general, higher total levels of all PL classes were observed in tumor cells. The overall PL profiles of the cell lines, when compared with the respective patient-derived cells, exhibited similarities. Nevertheless, there were also some notable differences in levels of individual PL species. This indicated that epithelial cell lines, derived either from normal colon tissue or from CRC cells, could be employed as models for functional lipidomic analyses of colon cells, albeit with some caution. The biological significance of the observed PL deregulation, or their potential links with specific CRC stages, deserve further investigation.
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a kolon $x patologie $7 D003106
650    _2
$a nádory tračníku $x metabolismus $x patologie $7 D003110
650    _2
$a epitelové buňky $x metabolismus $x patologie $7 D004847
650    _2
$a lidé $7 D006801
650    12
$a lipidomika $7 D000081362
650    _2
$a fosfolipidy $x metabolismus $7 D010743
650    _2
$a analýza hlavních komponent $7 D025341
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Slavík, Josef $u Veterinary Research Institute, Brno, Czech Republic.
700    1_
$a Ovesná, Petra $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic. Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Tylichová, Zuzana $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic.
700    1_
$a Dušek, Ladislav $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Straková, Nicol $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic.
700    1_
$a Vaculová, Alena Hyršlová $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic.
700    1_
$a Ciganek, Miroslav $u Veterinary Research Institute, Brno, Czech Republic.
700    1_
$a Kala, Zdeněk $u Department of Surgery, University Hospital Brno, Brno, Czech Republic.
700    1_
$a Jíra, Miroslav $u Department of Anesthesiology, Resuscitation and Intensive Care, University Hospital Brno, Brno, Czech Republic.
700    1_
$a Penka, Igor $u Department of Surgery, University Hospital Brno, Brno, Czech Republic.
700    1_
$a Kyclová, Jitka $u Department of Pathology, University Hospital Brno, Brno, Czech Republic.
700    1_
$a Kolář, Zdeněk $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic.
700    1_
$a Kozubík, Alois $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic. Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
700    1_
$a Machala, Miroslav $u Veterinary Research Institute, Brno, Czech Republic.
700    1_
$a Vondráček, Jan $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 15, č. 1 (2020), s. e0228010
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31999740 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214125514 $b ABA008
999    __
$a ok $b bmc $g 1595534 $s 1113891
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 15 $c 1 $d e0228010 $e 20200130 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
GRA    __
$a NV15-30585A $p MZ0
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Možnosti archivace